PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rimowa GmbH

USPTO PatentsView assignee record - 49 granted patents across 2 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A45C (PURSES; LUGGAGE; Hand Carried Bags).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rimowa ranks #6,833 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 2 technology areas.

#6,833
of 49,997 US assignees by volume
35th percentile
by Innovation Score (30.7/100)
2.5
avg claims per patent
-62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6833 · Foreign Corporation #6,833 · 49 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 49 grants
  • UPPER-Q #6,833/49,997
  • PHOTO-FINISH Principia Biopharma
  • CPC-NARROW A45C · 2 areas
  • INNOV-THIN 30.7/100
  • CLAIMS-SPARSE 2.5 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -62% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Principia Biopharma Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rimowa’s 30.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Rimowa

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Rimowa's Innovation Score is 30.7/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Rimowa?

Each dot is one of Rimowa’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rimowa’s own 2.5 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Rimowa vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 48.949.049.04949.049.049.1 0510152025 Granted patents (volume) Avg claims / patent Principia Biopharma Inc. - 49, 15.33Principia Biophar…Pulmonx Corporation - 49, 12.73PulmonxQlikTech International AB - 49, 19.35Qliktech Internat…Reata Pharmaceuticals Holdings, LLC - 49, 20.22Reata Pharmaceuti…Relievant Medsystems, Inc. - 49, 17.63Relievant Medsyst…Seegene, Inc. - 49, 17.12SeegeneSKF Magnetic Mechatronics - 49, 12.82SKF Magnetic Mech…Standard Cognition, Corp. - 49, 22.67Standard CognitionRimowa GmbH - 49, 2.47Rimowa
Rimowa vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rimowa's grants concentrate

Rimowa GmbH is a focused PatentsView assignee: 2 CPC subclasses with 14.3% of grants classified under A45C (PURSES; LUGGAGE; Hand Carried Bags). Peak complete grant year is 2017 (19 grants) versus a trough of 2 in 2015. By volume, Rimowa sits between Principia Biopharma Inc. and Standard Cognition, Corp..

Rimowa's three-year grant acceleration

Rimowa GmbH shows 8 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Rimowa's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rimowa holds 49 patents at rank #6,832, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rimowa

By rank, the assignees closest to #6,832 in granted patent volume.

Leaders in A45C (Purses)

Other assignees with the most granted patents in Rimowa's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rimowa, neither rank-band nor same-CPC leaders (those blocks stay above). In A45C (Purses), Rimowa ranks #47 of 494 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (31 here).

Spyderco, Inc. 31 Dundee Sustainable Technologies Inc. 31 Oncorus, Inc. 31 Moderna Therapeutics, Inc. 31

Rimowa's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 35th percentile higher than 35% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201520162017201820202021202220232025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Rimowa GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 4.1%
2016 3 6.1%
2017 19 38.8%
2018 10 20.4%
2020 2 4.1%
2021 3 6.1%
2022 3 6.1%
2023 5 10.2%
2025partial year 2 4.1%

Which technologies does Rimowa GmbH patent most?

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rimowa GmbH's patent record in context - here's where to go next.

  • Rimowa GmbH's lead technology class is A45C (PURSES; LUGGAGE; Hand Carried Bags), 14.3% of its portfolio - see every assignee active in that class. Explore A45C
  • Ranked #6,833 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Rimowa GmbH against Principia Biopharma Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.